Cite
HARVARD Citation
Loglio, A. et al. (n.d.). Safety and efficacy of up to 76 weeks 10 mg/day (high dose) bulevirtide monotherapy in compensated cirrhotics with delta hepatitis. Digestive and liver disease. pp. e28-e29. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Loglio, A. et al. (n.d.). Safety and efficacy of up to 76 weeks 10 mg/day (high dose) bulevirtide monotherapy in compensated cirrhotics with delta hepatitis. Digestive and liver disease. pp. e28-e29. [Online].